Skip to main content

Table 1 Comparison of clinical parameters between BCORMUT and BCORWT patients

From: Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Characteristics

BCOR mutated (n = 43)

BCOR wild-type (n = 633)

p

Age (mean) (year)

55.8

55.9

0.970

Sex (M/F) (no) (ratio)

24/19 (1.3)

371/262 (1.4)

0.719

Normal chromosomes (n) (%)

31/43 (72.1)

355/633 (56.1)

0.040

RAEB (1 + 2) (n) (%)

23/43 (53.5)

174/633 (27.5)

0.008

IPSS ≥ 1.5 (n) (%)

15/43 (34.9)

149/633 (23.5)

0.093

AML transformation ratio (n) (%)

11/43 (25.6)

97/633 (15.3)

0.076

Median overall survival (m)

32

36

0.214

AML free survival (m)

16

35

0.035

  1. The p value less than 0.05 is expressed in italics, suggesting a statistical difference